PDF Archive

Easily share your PDF documents with your contacts, on the Web and Social Networks.

Share a file Manage my documents Convert Recover PDF Search Help Contact



Global Organoid Technology Market.PDF


Preview of PDF document global-organoid-technology-market.pdf

Page 1 2 3 4 5 6 7 8

Text preview


DESCRIPTION
The global organoid technology market is expected to grow at a CAGR of XX.XX% to
reach a total market size of US$XX.XX Million by 2023, increasing from US$XX.XX Million
in 2018. Organoid technology refers to the growing of organs or ‘mini organs’ under lab
conditions. It is also referred to as 3D cell culture technology which leads to the organ
formation useful to replace, repair or regenerate any diseased tissue or organs and also
holds a great promise in cancer research. These mini organs reproduce out of stem cells
which have the power to regenerate themselves into a full organ or mass of cells or
tissue of a specific type. With a lot of research and commercial growth in the field of
stem cells and regenerative medicine, organoid technology stands out to have a
significant market.
STEMCELL Technologies, a leading organoid company has recently released
“IntestiCultTM Organoid Growth Medium” for supporting the maintenance of mouse
intestinal organoids. The company has also partnered with Institute of Molecular
Biotechnology (IMBA) in Vienna, Austria to develop “mini brains”. One of the main
advantage of the organoid technology is that mini organs can evade the use of harmful
animal testing. The importance of organoids is exemplified by the Human Cancer
Models Initiative (HCMI) which came into being in July 2016. Its aim is to develop a
large cell culture model bank along with its key participants National Cancer Institute,
Cancer Research UK, Wellcome Trust Sanger Institute and Hubrecht Organoid
Technology. Hence, this technology can bring out a market disruption and in long term
be a potential life- saver as well both for humans and animals. Some of the major
companies discussed in the report are Cellesce, Organoid Technologies GmbH, Hubrecht
Organoid Technology, BioTime, and Cell Therapies among others.
Research Methodology
The report provides a brief introduction to the market and deals with detailed research
methodology for calculating market size and forecasts, secondary data sources used and
the primary inputs which were taken for data validation. This section also outlines
various segmentation which has been covered as part of the report.

Global Organoid Technology Market - Industry Trends, Opportunities and Forecasts to
2023